IOL CHEMICALS & PHARM. | AMRUTANJAN HEALTHCARE | IOL CHEMICALS & PHARM./ AMRUTANJAN HEALTHCARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 12.4 | 40.6 | 30.4% | View Chart |
P/BV | x | 1.4 | 6.2 | 22.8% | View Chart |
Dividend Yield | % | 1.1 | 0.7 | 148.8% |
IOL CHEMICALS & PHARM. AMRUTANJAN HEALTHCARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
AMRUTANJAN HEALTHCARE Mar-23 |
IOL CHEMICALS & PHARM./ AMRUTANJAN HEALTHCARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 955 | 56.2% | |
Low | Rs | 272 | 553 | 49.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 129.9 | 290.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | 13.6 | 173.9% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 15.4 | 204.8% | |
Dividends per share (Unadj.) | Rs | 4.00 | 4.60 | 87.0% | |
Avg Dividend yield | % | 1.0 | 0.6 | 162.1% | |
Book value per share (Unadj.) | Rs | 256.8 | 99.1 | 259.1% | |
Shares outstanding (eoy) | m | 58.71 | 29.23 | 200.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 5.8 | 18.4% | |
Avg P/E ratio | x | 17.1 | 55.3 | 30.8% | |
P/CF ratio (eoy) | x | 12.8 | 48.9 | 26.2% | |
Price / Book Value ratio | x | 1.6 | 7.6 | 20.7% | |
Dividend payout | % | 16.9 | 33.8 | 50.0% | |
Avg Mkt Cap | Rs m | 23,743 | 22,038 | 107.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 488 | 344.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 3,796 | 584.0% | |
Other income | Rs m | 256 | 145 | 176.1% | |
Total revenues | Rs m | 22,427 | 3,942 | 569.0% | |
Gross profit | Rs m | 2,257 | 445 | 506.7% | |
Depreciation | Rs m | 462 | 52 | 885.6% | |
Interest | Rs m | 165 | 2 | 7,385.7% | |
Profit before tax | Rs m | 1,887 | 536 | 351.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 138 | 358.5% | |
Profit after tax | Rs m | 1,391 | 398 | 349.3% | |
Gross profit margin | % | 10.2 | 11.7 | 86.8% | |
Effective tax rate | % | 26.2 | 25.7 | 101.9% | |
Net profit margin | % | 6.3 | 10.5 | 59.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 2,595 | 372.4% | |
Current liabilities | Rs m | 5,025 | 630 | 797.5% | |
Net working cap to sales | % | 20.9 | 51.8 | 40.4% | |
Current ratio | x | 1.9 | 4.1 | 46.7% | |
Inventory Days | Days | 43 | 51 | 84.3% | |
Debtors Days | Days | 8 | 317 | 2.6% | |
Net fixed assets | Rs m | 11,017 | 983 | 1,120.8% | |
Share capital | Rs m | 587 | 29 | 2,008.6% | |
"Free" reserves | Rs m | 14,490 | 2,868 | 505.2% | |
Net worth | Rs m | 15,077 | 2,897 | 520.4% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 3,578 | 578.0% | |
Interest coverage | x | 12.5 | 241.6 | 5.2% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 1.1 | 101.0% | |
Return on assets | % | 7.5 | 11.2 | 67.2% | |
Return on equity | % | 9.2 | 13.7 | 67.1% | |
Return on capital | % | 13.6 | 18.6 | 73.2% | |
Exports to sales | % | 26.7 | 2.7 | 992.5% | |
Imports to sales | % | 0 | 0.8 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 102 | 5,796.2% | |
Imports (cif) | Rs m | NA | 30 | 0.0% | |
Fx inflow | Rs m | 5,930 | 102 | 5,796.2% | |
Fx outflow | Rs m | 6,052 | 30 | 20,308.1% | |
Net fx | Rs m | -122 | 73 | -167.8% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 202 | 605.9% | |
From Investments | Rs m | -1,200 | -25 | 4,848.5% | |
From Financial Activity | Rs m | -41 | -150 | 27.4% | |
Net Cashflow | Rs m | -18 | 27 | -67.7% |
Indian Promoters | % | 48.2 | 50.6 | 95.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 2.5 | 8.0 | 31.6% | |
FIIs | % | 2.2 | 0.8 | 272.5% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 49.4 | 104.9% | |
Shareholders | 134,235 | 68,404 | 196.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: SUN PHARMA DIVIS LABORATORIES CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | AMRUTANJAN HEALTH | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.31% | 1.22% | 1.18% |
1-Month | -9.26% | -4.61% | -0.75% |
1-Year | 29.97% | 4.11% | 61.82% |
3-Year CAGR | -13.41% | 3.91% | 18.16% |
5-Year CAGR | 13.41% | 14.83% | 19.79% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the AMRUTANJAN HEALTH share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of AMRUTANJAN HEALTH the stake stands at 50.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of AMRUTANJAN HEALTH.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
AMRUTANJAN HEALTH paid Rs 4.6, and its dividend payout ratio stood at 33.8%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of AMRUTANJAN HEALTH.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.